Du Yajing, Shao Shali, Lv Minghe, Zhu Yi, Yan Li, Qiao Tiankui
Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
Department of Radiation Oncology, Eye and ENT Hospital, Fudan University, Shanghai, China.
Front Oncol. 2020 Aug 26;10:1669. doi: 10.3389/fonc.2020.01669. eCollection 2020.
Both radiotherapy and surgery are now recommended for early stage glottic laryngeal squamous cell carcinoma (LSCC), and both have their own advantages in patients with different characteristics. For each patient, it is hard to determine whether radiotherapy or surgery is more appropriate.
Patients with T1-2N0M0 glottic LSCC who received radiotherapy or surgery in the 2004-2016 SEER database were reviewed, then randomly divided into training and validation cohorts. Propensity score matching was used to eliminate the baseline variations, and competing risk analyses helped to exclude the effects of other causes of death. Based on univariate and multivariate analyses, we built two nomograms to visually predict the survival of each patient with different characteristics who received radiotherapy or surgery, then validated the accuracy in both training and validation cohorts. Using nomogramEx, we quantified the algorithms of the nomograms and put the nomograms on the websites.
A total of 6538 patients in the SEER database were included. We found that therapy ( = 0.004), T stage ( < 0.001), age ( < 0.001), race ( < 0.044), grade ( = 0.001), and marital status ( < 0.001) were independent prognostic factors. Two nomograms were built to calculate the survival for each patient who received radiotherapy (C-index = 0.668 ± 0.050 in the training cohort and 0.578 ± 0.028 in the validation cohort) or underwent surgery (C-index = 0.772 ± 0.045 in the training cohort and 0.658 ± 0.090 in the validation cohort). Calibration plots showed the accuracy of the nomograms. Using the nomograms, we found that 3872 patients (59.22%) had no difference between the two therapies, 706 patients (10.80%) who received radiotherapy had better survival outcomes, and 1960 patients (29.98%) who underwent surgery had better survival outcome.
Nomograms were used to comprehensively calculate independent factors to determine which treatment (radiotherapy or surgery) is better for each patient. A website was used to offer guidance regarding surgery or radiation for patients and physicians.
目前,放射治疗和手术均被推荐用于早期声门型喉鳞状细胞癌(LSCC),且二者在不同特征的患者中各有优势。对于每一位患者而言,很难确定放射治疗或手术哪种更为合适。
回顾2004 - 2016年监测、流行病学与最终结果(SEER)数据库中接受放射治疗或手术的T1 - 2N0M0声门型LSCC患者,然后将其随机分为训练队列和验证队列。采用倾向得分匹配法消除基线差异,竞争风险分析有助于排除其他死亡原因的影响。基于单因素和多因素分析,我们构建了两个列线图,以直观预测接受放射治疗或手术的不同特征患者的生存情况,随后在训练队列和验证队列中验证其准确性。使用列线图分析软件(nomogramEx),我们对列线图的算法进行量化,并将列线图发布在网站上。
SEER数据库中共纳入6538例患者。我们发现治疗方式(P = 0.004)、T分期(P < 0.001)、年龄(P < 0.001)、种族(P < 0.044)、分级(P = 0.001)和婚姻状况(P < 0.001)是独立的预后因素。构建了两个列线图来计算接受放射治疗(训练队列中的C指数为0.668 ± 0.050,验证队列中的C指数为0.578 ± 0.028)或接受手术(训练队列中的C指数为0.772 ± 0.045,验证队列中的C指数为0.658 ± 0.090)的每位患者的生存情况。校准图显示了列线图的准确性。使用列线图,我们发现3872例患者(59.22%)在两种治疗方式之间无差异,706例接受放射治疗的患者(10.80%)生存结局更好,1960例接受手术的患者(29.98%)生存结局更好。
列线图用于综合计算独立因素,以确定哪种治疗(放射治疗或手术)对每位患者更合适。利用网站为患者和医生提供关于手术或放疗的指导。